 |
 |
Katelijne Matthys, MD, Ph.D., Medical Director
Dr Matthys joined OncoMethylome after having worked for 7 years in the Belgian subsidiary of Pfizer Pharmaceuticals. During that time, she held several positions in Medical and Clinical, her last position being Head of Medical Affairs & Clinical Research for hospital products. Prior to Pfizer, Dr Matthys worked for 3 years at Devgen, a biotech start-up at the time, as Pharmacologist and Project Leader.
At OncoMethylome, Dr Matthys is responsible for Clinical Development.
After obtaining her degree as a Medical Doctor at Ghent University, Dr Matthys worked as general physician for some years. She then followed a PhD programme in Toxicology and Pharmacology at Rutgers University, New Jersey, and earned her PhD in Medical Sciences from the University of Antwerp .
|